Kite Pharma, Inc. portfolio
United States
Every trademark Kite Pharma, Inc. holds, newest filings first. The portfolio has 575 marks filed under 18 owner names.
Search this portfolio
- Trademarks on file
- 575
- Active
- 396
- Owner names grouped
- 18
Portfolio
All trademarks
50 marks per page, newest filing date first. Pick an office to narrow the list.
| Mark | Status | Office | Classes | Filed |
|---|---|---|---|---|
| XOTUVLI | examining | USPTO | 5 | 2026-11-02 |
| DURBILICY | examining | USPTO | 5 | 2026-11-02 |
| NEXBIXYS | examining | USPTO | 5 | 2026-11-02 |
| CAR T REFERRAL ATLAS | examining | USPTO | 44 | 2026-10-27 |
| SYTUVLY | examining | USPTO | 5 | 2026-10-22 |
| TUVYCARZ | examining | USPTO | 5 | 2026-10-22 |
| TUVQURTI | examining | USPTO | 5 | 2026-10-22 |
| YORTUVCAR | examining | USPTO | 5 | 2026-10-22 |
| YORTUVLY | examining | USPTO | 5 | 2026-10-22 |
| BICIMBIK | examining | USPTO | 5 | 2026-10-22 |
| BYCITUVE | examining | USPTO | 5 | 2026-10-22 |
| BYCURTI | examining | USPTO | 5 | 2026-10-22 |
| BYCILGO | examining | USPTO | 5 | 2026-10-22 |
| BYEXPO | examining | USPTO | 5 | 2026-10-22 |
| BYQURTI | examining | USPTO | 5 | 2026-10-22 |
| BYTUSTRO | examining | USPTO | 5 | 2026-10-22 |
| FYNEXXTO | examining | USPTO | 5 | 2026-10-22 |
| KARTAQUEX | examining | USPTO | 5 | 2026-10-22 |
| KARTUQUESS | examining | USPTO | 5 | 2026-10-22 |
| MAVTRONIQ | examining | USPTO | 5 | 2026-10-22 |
| MYTUCARA | examining | USPTO | 5 | 2026-10-22 |
| MODISFRI | examining | USPTO | 5 | 2026-10-22 |
| MYTUCDI | examining | USPTO | 5 | 2026-10-22 |
| MYBICELZ | examining | USPTO | 5 | 2026-10-22 |
| TOMNEXXRO | examining | USPTO | 5 | 2026-10-22 |
| PANJAQART | examining | USPTO | 5 | 2026-10-22 |
| QURPAXTEO | examining | USPTO | 5 | 2026-10-22 |
| RYVNEXXO | examining | USPTO | 5 | 2026-10-22 |
| TUVCARLY | examining | USPTO | 5 | 2026-10-22 |
| TUVTARQO | examining | USPTO | 5 | 2026-10-22 |
| VICDISFRI | examining | USPTO | 5 | 2026-10-22 |
| YESCARTA | filed | IMPI | 5 | 2026-07-15 |
| YESCARTA | filed | IMPI | 44 | 2026-07-15 |
| KITE KONNECT | filed | IMPI | 5 | 2026-06-26 |
| MMOREINFORMED | mixed | WIPO | 44 | 2026-06-02 |
| [Design Mark] | registered | EUIPO | 5, 44 | 2026-04-20 |
| ZENDDMYA | registered | EUIPO | 5, 44 | 2026-04-20 |
| tm_6319abb7-283a-44af-b037-f5c82f551fe2 | mixed | WIPO | 5 | 2026-04-16 |
| ZENDDMYA | mixed | WIPO | 5 | 2026-04-16 |
| KITE | registered | IMPI | 5 | 2026-01-16 |
| KITE DUOCORE | examining | USPTO | 5, 40 | 2025-12-19 |
| KNOWMMORE | abandoned | USPTO | 44 | 2025-12-19 |
| MMOREINFORMED | allowed | USPTO | 44 | 2025-12-19 |
| FOCUSED ON THE CURE | allowed | USPTO | 44 | 2025-12-19 |
| JENDDMYA | allowed | USPTO | 5 | 2025-11-04 |
| ZENDDMYA | allowed | USPTO | 5 | 2025-11-04 |
| linfo + | registered | EUIPO | 41, 44 | 2025-10-31 |
| [Design Mark] | allowed | USPTO | 5 | 2025-10-27 |
| KITE | allowed | USPTO | 5 | 2025-09-05 |
| CELL THERAPY HUB | withdrawn | EUIPO | 41, 44 | 2025-07-28 |
API
Get this data via the API
Everything on this page comes from the Signa API. Pull Kite Pharma, Inc.'s full portfolio into your own product.
GET/v1/entities/{id}/trademarksEvery trademark in the portfolio, filterable by office and class
GET/v1/entities/{id}/analyticsPortfolio totals, disputes and ownership changes
GET/v1/entities/{id}Company record, ticker, LEI and owner names
GET /v1/entities/{id}/trademarks
ID=ent_019ebb01-c91d-76c9-8a8c-012bbefadcab
curl https://api.signa.so/v1/entities/$ID/trademarks \
-H "Authorization: Bearer $SIGNA_API_KEY"Response
{
"object": "list",
"data": [
{
"id": "tm_01a1a18b-d43a-748c-ba82-17291a64d242",
"mark_text": "XOTUVLI",
"office_code": "US",
"status": {
"stage": "examining"
},
"filing_date": "2026-11-02"
},
{
"id": "tm_01a1a18b-d4c2-76dc-8ca2-6fe549a39e77",
"mark_text": "DURBILICY",
"office_code": "US",
"status": {
"stage": "examining"
},
"filing_date": "2026-11-02"
}
],
"has_more": true
}